JP Stock MarketDetailed Quotes

4521 Kaken Pharmaceutical

Watchlist
  • 4065.0
  • 0.00.00%
20min DelayTrading Jul 26 15:00 JST
186.75BMarket Cap19.11P/E (Static)

Kaken Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kaken Pharmaceutical Earnings Date

Currency: JPY

Period

Q4 FY2024 Earnings

May 14, 2024

Revenue(YoY)

17.36B

-0.30%
EPS(YoY)

35.57

+135.94%
Analyst Rating

Hold

Jul 11, 2024

Kaken Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20242024/Q318.514B / ----
Aug 4, 20232024/Q118.150B / ----
Feb 3, 20232023/Q318.754B / ----
Aug 3, 20222023/Q118.197B / ----
Feb 3, 20222022/Q320.120B / ----
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20242024/Q318.514B / ----
Aug 4, 20232024/Q118.150B / ----
Feb 3, 20232023/Q318.754B / ----
Aug 3, 20222023/Q118.197B / ----
Feb 3, 20222022/Q320.120B / ----

Unlock Free Earnings Estimates

Kaken Pharmaceutical Earnings Reports

  • Kaken Pharmaceutical: Interim report

    Jun 30 21:36 ET

  • Kaken Pharmaceutical: Confirmatory letter.

    Jun 27 02:08 ET

  • Kaken Pharmaceutical: Securities Report - 104th term (April 1, 2023 - March 31, 2024)

    Jun 27 02:06 ET

  • Kaken Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

    May 14 00:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 11, 2024

    Hold

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      100.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg